Form 4: Cardinal Health Director Killefer Granted RSUs

Cardinal Health director Nancy Killefer was granted 1,067 restricted share units, increasing her direct beneficial ownership to 27,624 common shares.

Summary

• Nancy Killefer, a Director of Cardinal Health Inc. (CAH), was granted 1,067 restricted share units (RSUs).
• The transaction date for this acquisition was November 5, 2025.
• These RSUs were granted at a price of $0, indicating they are part of a compensation package.
• Following this transaction, Killefer directly beneficially owns 27,624 common shares of Cardinal Health.
• The RSUs are scheduled to vest on November 5, 2026, or earlier if the 2026 Annual Meeting of Shareholders occurs before that date.
• The filing was signed by James E. Barnett, Attorney-in-fact, on November 6, 2025, under a Limited Power of Attorney.

Sentiment

Score: 7

Explanation: The grant of restricted share units to a director is generally a positive signal as it aligns insider interests with long-term shareholder value. It's a routine compensation event, so the positive impact is moderate rather than highly significant.

Positives

• An insider, Nancy Killefer, acquired 1,067 restricted share units, aligning her interests with shareholders.
• The grant increases her direct beneficial ownership in Cardinal Health to 27,624 common shares.

Risks

• The Limited Power of Attorney explicitly states that neither Cardinal Health nor the attorneys-in-fact assume any liability for Nancy Killefer's responsibility to comply with SEC requirements (Exchange Act or Securities Act), any failure to comply, or any obligation for profit disgorgement under Section 16(b) of the Exchange Act.
• Nancy Killefer remains solely responsible for compliance with her obligations under the Exchange Act and Securities Act.

Future Outlook

The 1,067 restricted share units granted to Nancy Killefer are scheduled to vest on November 5, 2026, or on the date of the 2026 Annual Meeting of Shareholders if it occurs before November 5, 2026.

Industry Context

This filing is a routine disclosure of insider compensation for a director at Cardinal Health, a major healthcare services and products company. Such grants are common practice for aligning director interests with long-term company performance.

Corporate Governance

Stakeholder Impact

• Shareholders: The grant of restricted share units to a director aligns her interests with long-term shareholder value, as the value of her compensation is tied to the company's stock performance.

Next Steps

• The restricted share units are expected to vest on November 5, 2026, or the date of the 2026 Annual Meeting of Shareholders if earlier.

Key Dates

Recommendation

This Form 4 filing details a routine grant of restricted share units to a director as part of their compensation. While it indicates insider alignment, it does not present new fundamental information about the company's operations, financial performance, or strategic direction that would warrant a change in investment recommendation. It's an expected event for a publicly traded company's board member.

Keywords

Cardinal Health, CAH, Nancy Killefer, Director, Restricted Share Units, RSU Grant, Insider Ownership, SEC Form 4, Corporate Governance, Executive Compensation